Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 4 2Phase 2 2Phase NA 1Phase 2/3 1Phase 1/2 1Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Urologic Diseases 1Urinary Retention 1Urinary Bladder Neoplasms 1Thrombocytopenia 1Prostatic Neoplasms 1Patient Satisfaction 1Neoplasms 1Hemostatic Disorders 1Hemorrhage 1Hematuria 1

Interventions

Tranexamic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Hemorrhage × Tranexamic Acid × Clear all
NCT06023212 2025-02-10

Tranexamic Acid Use for Bleeding Prevention in the Surgical Treatment of Metastatic Spinal Tumor in Lung Cancer Patients

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 1/2 Recruiting
150 enrolled

Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon âš¡